Science Friday > Archives > 2004 > October > October 15, 2004:
Hour One: Vioxx/Drug Testing, Stem Cell research (Christopher Reeve)

Last month, drug company Merck pulled its blockbuster pain reliever Vioxx off the market, citing safety concerns. In this hour, we'll take a look at the life of Vioxx and the business of testing drugs.

Plus, a stem cell update: we'll talk about state funding for stem cell work, new research guidelines, and whether actor Christopher Reeve's death will make stem cell research a key issue in the election.

Guests:

Laurie Zoloth
Professor, Medical Ethics and Humanities
Director of Bioethics, Center for Genetic Medicine
Feinberg School of Medicine
Professor of Religion
Northwestern University
Chicago, Illinois

---------------

Alastair Wood, M.D.
Professor of Medicine
Professor of Pharmacology
Associate Dean
Vanderbilt University Medical School
Nashville, Tennesee

Jerry Avorn, M.D.
Author, "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs" (Knopf, 2004)

Associate Professor of Medicine
Harvard Medical School
Chief, Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital
Boston, Massachusetts

This segment produced by Karin Vergoth

Archived Audio:
stem cells
listen in RealAudio format
listen in Windows Media format

drug testing
listen in RealAudio format
listen in Windows Media format

Related Links:

Books/Articles Discussed:

(find books discussed on previous broadcasts)

Search by keywords: